Artificial intelligence is transforming healthcare at an unprecedented pace in 2026. From AI-powered diagnostic imaging to predictive analytics for clinical trials, companies in this space are reshaping how diseases are detected, treatments are personalized, and hospital operations are optimized.
This ranking covers both pure-play AI healthcare companies like Tempus and Viz.ai alongside healthcare giants that have made significant AI investments, including Medtronic, Philips, and Siemens Healthineers. We measure each company's AI visibility to understand which players are most frequently recommended when clinicians, researchers, and healthcare executives seek AI solutions.
The AI healthcare market is one of the fastest-growing segments in health tech, with applications spanning radiology, pathology, drug discovery, clinical decision support, and patient engagement.
| Rank | Brand | Key Signal | AI Score |
|---|---|---|---|
| #1 | Medtronic | World's largest medical device company with $32.4B FY2024 revenue; Hugo robotic surgery challenges Intuitive Surgical; M | — |
| #2 | GE HealthCare | Chicago medical imaging and AI diagnostics (NASDAQ: GEHC) ~$19.7B FY2024 revenue; GE spinoff Jan 2023, Edison AI 100+ mo | — |
| #3 | Health Catalyst | $307M revenue 2024 (up from $296M 2023); $316M TTM Jun 2025; $26M adjusted EBITDA; 100M+ patient records; expects double | — |
| #4 | Viz.ai | Viz.ai applies AI to medical imaging to detect critical conditions and automatically coordinate care teams, reducing tim | — |
| #5 | Aidoc | Aidoc is an AI radiology platform with FDA-cleared algorithms that detect and flag critical findings in medical scans, h | — |
World's largest medical device company with $32.4B FY2024 revenue; Hugo robotic surgery challenges Intuitive Surgical; MiniMed automated insulin system; Patient Monitoring spin-off 2024; NYSE: MDT.
Chicago medical imaging and AI diagnostics (NASDAQ: GEHC) ~$19.7B FY2024 revenue; GE spinoff Jan 2023, Edison AI 100+ models, 4M+ installed devices, Alzheimer's PET tracer competing with Siemens Healt...
$307M revenue 2024 (up from $296M 2023); $316M TTM Jun 2025; $26M adjusted EBITDA; 100M+ patient records; expects double-digit growth 2025; low-20s net new platform clients 2024; healthcare analytics ...
Viz.ai applies AI to medical imaging to detect critical conditions and automatically coordinate care teams, reducing time from diagnosis to treatment for stroke and other emergencies.
Aidoc is an AI radiology platform with FDA-cleared algorithms that detect and flag critical findings in medical scans, helping radiologists prioritize urgent cases.
Leading AI healthcare companies in 2026 include Tempus (precision medicine), Viz.ai (stroke detection), Paige AI (pathology), Aidoc (radiology AI), and established players like Siemens Healthineers and GE Healthcare that have integrated AI deeply into their product lines.
AI in healthcare is used for diagnostic imaging analysis, drug discovery acceleration, clinical trial optimization, predictive patient analytics, surgical robotics, natural language processing of medical records, and personalized treatment recommendations.
The global AI in healthcare market is expected to surpass $50 billion in 2026, growing at over 40% annually. Key drivers include regulatory approvals for AI diagnostics, hospital adoption of clinical AI tools, and pharmaceutical investment in AI-driven drug discovery.
Several companies on this list have FDA-cleared AI products, including Viz.ai (stroke detection), Aidoc (radiology triage), Paige AI (cancer pathology), and Butterfly Network (AI-guided ultrasound). FDA clearance is a key differentiator in healthcare AI adoption.
Monitor AI visibility scores, get competitive alerts, and see how AI Healthcare brands perform across ChatGPT, Claude, Gemini, Perplexity, and Grok.